RBLX three-lens brief
Evidence-based stock research on RBLX. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -2.80% yesterday. · Trading at 13% of its 52-week range — deep in the lower band.
- Moved -2.80% yesterday.
- Trading at 13% of its 52-week range — deep in the lower band.
- Outperforming SPY by 19.8pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $65.97 — 20% above current (31 analysts).
RBLX closed at $54.85 (-2.80%) as of 2026-07-10. Market cap: $39.27B. Price is above the 50-day MA and below the 200-day MA. Positives: outperforming SPY by 19.8pp over 30 days.; analyst mean target $65.97 — 20% above current (31 analysts).. Concerns: moved -2.80% yesterday.; trading at 13% of its 52-week range — deep in the lower band.. Last quarter: Revenue $1.73B, net income -$246.00M, free cash flow $1.20B. Watching for: 2026-07-30 earnings release (19 days out).
Why three lenses on RBLX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine RBLXacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/RBLX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath RBLX brief"></iframe>